ENL Stock Overview
Operates in the healthcare IT sector in the United States, Europe, and Japan.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Enlitic, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.062 |
52 Week High | AU$1.01 |
52 Week Low | AU$0.049 |
Beta | 0 |
11 Month Change | -11.43% |
3 Month Change | -43.64% |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -92.71% |
Recent News & Updates
Recent updates
Shareholder Returns
ENL | AU Healthcare Services | AU Market | |
---|---|---|---|
7D | 6.9% | 4.7% | -0.5% |
1Y | n/a | 131.6% | 19.4% |
Return vs Industry: Insufficient data to determine how ENL performed against the Australian Healthcare Services industry.
Return vs Market: Insufficient data to determine how ENL performed against the Australian Market.
Price Volatility
ENL volatility | |
---|---|
ENL Average Weekly Movement | 18.5% |
Healthcare Services Industry Average Movement | 8.1% |
Market Average Movement | 8.7% |
10% most volatile stocks in AU Market | 17.8% |
10% least volatile stocks in AU Market | 3.6% |
Stable Share Price: ENL's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: ENL's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2014 | n/a | Michael Sistenich | www.enlitic.com |
Enlitic, Inc. operates in the healthcare IT sector in the United States, Europe, and Japan. The company uses artificial intelligence (AI) to develop software products that manage medical imaging data in radiology, such as magnetic resonance imaging, computed tomography scans, X-ray, and ultrasound images, and licenses such products to healthcare providers and original equipment manufacturers. Its healthcare data solutions include ENDEX, a medical imaging solution that standardizes and structures data from medical images; and ENCOG, a solution designed to de-identify medical imaging data while retaining clinically relevant information.
Enlitic, Inc. Fundamentals Summary
ENL fundamental statistics | |
---|---|
Market cap | AU$34.01m |
Earnings (TTM) | -AU$21.55m |
Revenue (TTM) | AU$650.38k |
53.1x
P/S Ratio-1.6x
P/E RatioIs ENL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ENL income statement (TTM) | |
---|---|
Revenue | US$427.69k |
Cost of Revenue | US$781.41k |
Gross Profit | -US$353.72k |
Other Expenses | US$13.82m |
Earnings | -US$14.17m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.025 |
Gross Margin | -82.71% |
Net Profit Margin | -3,313.32% |
Debt/Equity Ratio | 0% |
How did ENL perform over the long term?
See historical performance and comparison